TY - JOUR
T1 - Review of pulmonary toxicity of indium compounds to animals and humans
AU - Tanaka, Akiyo
AU - Hirata, Miyuki
AU - Kiyohara, Yutaka
AU - Nakano, Makiko
AU - Omae, Kazuyuki
AU - Shiratani, Masaharu
AU - Koga, Kazunori
N1 - Funding Information:
This study was funded in part by a Grant-in-Aid for Scientific Research (A) (20249039) and Research (B) (19390164) from the Ministry of Education, Culture, Sports, Science and Technology of Japan . The English used in this manuscript was revised by Miss K. Miller (Royal English Language Centre, Fukuoka, Japan).
PY - 2010/3/31
Y1 - 2010/3/31
N2 - Due to the increased production of ITO, the potential health hazards arising from occupational exposure to this material have attracted much attention. This review consists of three parts: 1) toxic effects of indium compounds on animals, 2) toxic effects of indium compounds on humans, and 3) recommendations for preventing exposure to indium compounds in the workplace. Available data have indicated that insoluble form of indium compounds, such as ITO, indium arsenide (InAs) and indium phosphide (InP), can be toxic to animals. Furthermore, InP has demonstrated clear evidence of carcinogenic potential in long-term inhalation studies using experimental animals. As for the dangers to humans, some data are available concerning adverse health effects to workers who have been exposed to indium-containing particles. The Japan Society for Occupational Health recommended the value of 3 μg/L of indium in serum as the occupational exposure limit based on biological monitoring to preventing adverse health effects in workers resulting from occupational exposure to indium compounds. Accordingly, it is essential that much greater attention is focused on human exposure to indium compounds, and precautions against possible exposure to indium compounds are most important with regard to health management among indium-handling workers.
AB - Due to the increased production of ITO, the potential health hazards arising from occupational exposure to this material have attracted much attention. This review consists of three parts: 1) toxic effects of indium compounds on animals, 2) toxic effects of indium compounds on humans, and 3) recommendations for preventing exposure to indium compounds in the workplace. Available data have indicated that insoluble form of indium compounds, such as ITO, indium arsenide (InAs) and indium phosphide (InP), can be toxic to animals. Furthermore, InP has demonstrated clear evidence of carcinogenic potential in long-term inhalation studies using experimental animals. As for the dangers to humans, some data are available concerning adverse health effects to workers who have been exposed to indium-containing particles. The Japan Society for Occupational Health recommended the value of 3 μg/L of indium in serum as the occupational exposure limit based on biological monitoring to preventing adverse health effects in workers resulting from occupational exposure to indium compounds. Accordingly, it is essential that much greater attention is focused on human exposure to indium compounds, and precautions against possible exposure to indium compounds are most important with regard to health management among indium-handling workers.
KW - ITO
KW - Indium
KW - Indium arsenide
KW - Indium phosphide
KW - Interstitial pneumonia
KW - Pulmonary toxicity
UR - http://www.scopus.com/inward/record.url?scp=77649160175&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=77649160175&partnerID=8YFLogxK
U2 - 10.1016/j.tsf.2009.10.123
DO - 10.1016/j.tsf.2009.10.123
M3 - Review article
AN - SCOPUS:77649160175
SN - 0040-6090
VL - 518
SP - 2934
EP - 2936
JO - Thin Solid Films
JF - Thin Solid Films
IS - 11
ER -